Gavard, Marylaure
21  results:
Search for persons X
?
3

Medication errors reporting in drug clinical trials: Role o..:

Delavoipière, Elodie ; Fourage, Chloé ; Macro, Margaret...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2021.02.002.  , 2021
 
?
4

Medication errors reporting in drug clinical trials: Role o..:

Delavoipière, Elodie ; Fourage, Chloé ; Macro, Margaret...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2021.02.002.  , 2021
 
?
5

Medication errors reporting in drug clinical trials: Role o..:

Delavoipière, Elodie ; Fourage, Chloé ; Macro, Margaret...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2021.02.002.  , 2021
 
?
6

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
7

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
8

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
9

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
10

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
11

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
12

Medication errors reporting in drug clinical trials: Role o..:

Delavoipière, Elodie ; Fourage, Chloé ; Macro, Margaret...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2021.02.002.  , 2021
 
?
13

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
Verry , C , Dufort , S , Villa , J , Gavard , M , Iriart , C , Grand , S , Charles , J , Chovelon , B , Cracowski , J-L , Quesada , J-L , Mendoza , C , Sancey , L , Lehmann , A , Jover , F , Giraud , J-Y , Lux , F , Crémillieux , Y , McMahon , S , Pauwels , P J , Cagney , D , Berbeco , R , Aizer , A , Deutsch , E , Loeffler , M , Le Duc , G , Tillement , O & Balosso , J 2021 , ' Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) ' , Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology , vol. 160 , pp. 159-165 . https://doi.org/10.1016/j.radonc.2021.04.021.  , 2021
 
?
14

Theranostic AGuIX nanoparticles as radiosensitizer: A phase..:

Verry, Camille ; Dufort, Sandrine ; Villa, Julie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2021.04.021.  , 2021
 
?
15

Compliance of French academic clinical trials with the Clin..:

Crepin, Sabrina ; Chiffoleau, Anne ; Gavard, Marylaure...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1740774520903720.  , 2020
 
1-15